| 名稱 | BCR-ABL1 I502L/BaF3 |
| 型號 | CBP73309 |
| 報價 |  |
| 特點 | BCR-ABL1 [I502L]/BaF3,母細胞：BaF3，凍存條件：90% FBS+10% DMSO；ABL1 是一種酪氨酸激酶，在正常細胞中，它在細胞分化和細胞周期調(diào)節(jié)中發(fā)揮作用。 BCR-ABL1 融合基因產(chǎn)生一種組成型活性酪氨 |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
產(chǎn)品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73309BCR-ABL1 I502L/BaF3
- 詳細內(nèi)容
| CBP73309 | |
| I. Introduction | |
Cell Line Name： | BCR-ABL1 [I502L]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
| III. Representative Data | |
1.WB of BCR-ABL1 [I502L]/BaF3
| |
2.Sanger of BCR-ABL1 [I502L]/BaF3 Figure 2. BCR-ABL1 [I502L]/BaF3 I502L
Figure 3. BCR-ABL1 [I502L]/BaF3 Fusion | |
3. Anti-proliferation assay
Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 I502L Cells (C2). | |
